Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash(reuters.com)

2 pointsby randycupertino5 months ago3 comments

Novo Nordisk sues Hims after $49 weight-loss pill sparks FDA backlash

https://www.reuters.com/sustainability/boards-policy-regulation/novo-nordisk-shares-rise-hims-abandons-49-weight-loss-pill-2026-02-09/

3 comments

randycupertino5 months ago

Novo's stock jumped 8% on this news, and HIMS pulled their compounded weightloss pill in the face of mounting legal and regulatory pressure.

Feel like the next shoe to drop will be supply chain- going after API suppliers and the compounders.

dlcarrier5 months ago

Their international patents expire this year, so it'll become a game of whack-a-mole trying to stop individuals from importing generics.

simplyvibecode5 months ago

No surprise